Literature DB >> 8360854

Estimation of variance for AUC in animal studies.

J Yuan.   

Abstract

Mesh：

Year:  1993        PMID： 8360854     DOI： 10.1002/jps.2600820718

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  43 in total

1.  Variability of the model-independent AUC: the one sample per individual case.

Authors:  W Jawień
Journal:  J Pharmacokinet Biopharm       Date:  1999-08

2.  Enhanced accumulation of sialyl Lewis X-carboxymethylpullulan conjugate in acute inflammatory lesion.

Authors:  K Horie; M Sakagami; K Kuramochi; K Hanasaki; H Hamana; T Ito
Journal:  Pharm Res       Date:  1999-02       Impact factor: 4.200

3.  Significant reduction of brain cysts caused by Toxoplasma gondii after treatment with spiramycin coadministered with metronidazole in a mouse model of chronic toxoplasmosis.

Authors:  Wai Kit Chew; Ignacio Segarra; Stephen Ambu; Joon Wah Mak
Journal:  Antimicrob Agents Chemother       Date:  2012-01-23       Impact factor: 5.191

4.  Estimation of AUC from 0 to Infinity in Serial Sacrifice Designs.

Authors:  Martin Josef Wolfsegger; Thomas Jaki
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-12       Impact factor: 2.745

5.  Establishing bioequivalence in serial sacrifice designs.

Authors:  Martin J Wolfsegger
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-10-12       Impact factor: 2.745

6.  Estimation of confidence intervals for area under the curve from destructively obtained pharmacokinetic data.

Authors:  R C Gagnon; J J Peterson
Journal:  J Pharmacokinet Biopharm       Date:  1998-02

7.  Bayesian approach to estimate AUC, partition coefficient and drug targeting index for studies with serial sacrifice design.

Authors:  Tianli Wang; Kyle Baron; Wei Zhong; Richard Brundage; William Elmquist
Journal:  Pharm Res       Date:  2013-10-03       Impact factor: 4.200

8.  Pharmacokinetics and pharmacodynamics of piperaquine in a murine malaria model.

Authors:  Brioni R Moore; Kevin T Batty; Christopher Andrzejewski; Jeffrey D Jago; Madhu Page-Sharp; Kenneth F Ilett
Journal:  Antimicrob Agents Chemother       Date:  2007-11-05       Impact factor: 5.191

9.  Comparison of tenofovir plasma and tissue exposure using a population pharmacokinetic model and bootstrap: a simulation study from observed data.

Authors:  Jon W Collins; J Heyward Hull; Julie B Dumond
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-11-08       Impact factor: 2.745

10.  Cisplatin and oxaliplatin toxicity: importance of cochlear kinetics as a determinant for ototoxicity.

Authors:  Victoria Hellberg; Inger Wallin; Sofi Eriksson; Emma Hernlund; Elin Jerremalm; Maria Berndtsson; Staffan Eksborg; Elias S J Arnér; Maria Shoshan; Hans Ehrsson; Göran Laurell
Journal:  J Natl Cancer Inst       Date:  2008-12-30       Impact factor: 13.506
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.